期刊文献+

硅油填充眼手法小切口与超声乳化白内障手术的并发症(英文) 被引量:5

Complication of manual small incision cataract surgery and phacoemulsification in previously vitrectomized eyes with silicone oil tamponade
下载PDF
导出
摘要 目的:比较超声乳化联合硅油取出术与硅油填充眼手法小切口白内障手术(MSICS)的安全性。方法:回顾性对比研究。162例患者162眼接受白内障手术,超声乳化联合硅油取出术与硅油填充眼手法小切口白内障手术均行玻璃体切除。结果:超声乳化白内障手术组术后低眼压21眼(18.91%)MSICS组术后低眼压8眼(15.68%),两组间无明显统计学差异(P=0.666)。术后1mo两组间视网膜复位率无明显统计学意义;超声乳化白内障手术组8例患者(7.2%)复发,硅油填充眼手法小切口白内障手术组9例(17.64%)复发,两组复发率比较,差异无统计学意义(P=0.055)。结论:硅油填充眼手法小切口白内障手术相较于超声乳化联合硅取出术在低眼压、渗漏、脉络膜脱离、视网膜复位率方面结果无劣效性。 AIM: To compare the safety between phacoemulsification and manual small incision cataract surgery(MSICS)combined with silicone oil removal in previously vitrectomized eyes. METHODS:A retrospective comparative no-inferiority study to 162 patients(162 eyes)who undergone cataract surgery, either phacoemulsification or MSICS combined with silicone oil removal which had pars plana vitrectomy.RESULTS:There were no statistically significant different in hypotony between phacoemulsification group(21 patients; 18.91%)and MSICS group(8 patients; 15.68%)(P=0.666). There was also no statistically significant different between two group in 1mo retinal reattachment rate; 8 patients(7.2%)in phacoemulsification group had redetachment compared with 9 patients(17.64%)in MSICS combined with silicone oil removal group(P=0.055).CONCLUSION:MSICS combined with silicone oil removal has non-inferiority result to phacoemulsification combined with silicone oil removal in hypotony, leakage, choroidal detachment and retinal reattachment rate.
出处 《国际眼科杂志》 CAS 北大核心 2018年第2期203-206,共4页 International Eye Science
关键词 手法小切口白内障手术 超声乳化白内障手术 璃体切除术后眼 manual small incision cataract surgery phacoemulsification vitrectomized eyes
  • 相关文献

参考文献1

二级参考文献18

  • 1Elagouz M,Stanescu-Segall D,Jackson TL.Uveal effusion syndrome.Surv Ophthalmol 2010; 55:134-45.
  • 2Schepens CL,Brockhurst RJ.Uveal effusion.1.clinical picture.Arch Ophthalmol 1963; 70:189-201.
  • 3Uyama M,Takahashi K,Kozaki J,et al.Uveal effusion syndrome:clinical features,surgical treatment,histologic examination of the sclera,and pathophysiology.Ophthalmology 2000; 107:441-9.
  • 4Roesel M,Heinz C,Heiligenhaus A.H1N1 and uveal effusion syndrome.Ophthalmology 2010; 117:1467-e1.
  • 5Park SH,Song SJ.Castleman's disease presenting with uveal effusion syndrome.Korean J Ophthalmol 2010;24:182-5.
  • 6Fledelius HC,Fuchs HJ,Jensen PK,et al.Uveal effusion and ultrasonic imaging:a clinical series.Acta Ophthalmol Scand 2002; 80:202-10.
  • 7Gass JD.Uveal effusion syndrome:a new hypothesis concerning pathogenesis and technique of surgical treatment.Retina 2003; 23:159-63.
  • 8Jackson TL,Hussain A,Morley AM,et al.Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.Invest Ophthalmol Vis Sci 2008;49:5033-40.
  • 9Suzuki Y,Nishina S,Azuma N.Scleral window surgery and topical mitomycin C for nanophthalmic uveal effusion complicated by renal failure:case report.Graefes Arch Clin Exp Ophthalmol 2007; 245:755-7.
  • 10Trelstad RL,Silbermann NN,Brockhurst RJ.Nanophthalmic sclera:ultrastructural,histochemical,and biochemical observations.Arch Ophthalmol 1982; 100:1935-8.

共引文献3

同被引文献26

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部